ABVC BioPharma Inc (ABVC)
1.59
+0.11
(+7.43%)
USD |
NASDAQ |
Apr 25, 16:00
1.53
-0.06
(-3.77%)
Pre-Market: 09:16
ABVC BioPharma Revenue (TTM): 0.1524M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.1524M |
September 30, 2023 | 0.7393M |
June 30, 2023 | 0.7656M |
March 31, 2023 | 1.072M |
December 31, 2022 | 0.9698M |
September 30, 2022 | 0.343M |
June 30, 2022 | 0.3997M |
March 31, 2022 | 0.1183M |
December 31, 2021 | 0.3558M |
September 30, 2021 | 0.4558M |
June 30, 2021 | 0.4723M |
March 31, 2021 | 0.6674M |
December 31, 2020 | 0.483M |
September 30, 2020 | 0.5208M |
June 30, 2020 | 0.603M |
March 31, 2020 | 0.5683M |
December 31, 2019 | 0.7017M |
September 30, 2019 | 0.5978M |
June 30, 2019 | 0.4008M |
March 31, 2019 | 0.2122M |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.1183M
Minimum
Mar 2022
1.072M
Maximum
Mar 2023
0.5467M
Average
0.5208M
Median
Sep 2020
Revenue (TTM) Benchmarks
NeuBase Therapeutics Inc | -- |
Sutro Biopharma Inc | 153.73M |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | 76.86M |
Journey Medical Corp | 79.18M |